Showing results (21-30 of 261) with videos related to
Sort By:
Pageof 27
British Journal of Haematology|August 16, 2023
Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvementChristine E Ryan, Rebecca L Zon, Robert Redd, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 21, 2015
Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel ImmunotherapiesMiguel-Angel Perales, Craig S Sauter, Philippe ArmandBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2016
Reprint of: Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel ImmunotherapiesMiguel-Angel Perales, Craig S Sauter, Philippe ArmandBlood|March 18, 2024
Frontline management of mantle cell lymphomaChristine E Ryan, Philippe Armand, Ann S LaCasceEuropean Journal of Cancer (Oxford, England : 1990)|July 4, 2020
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?Roch Houot, Ronald Levy, Guillaume Cartron, et al.European Journal of Cancer (Oxford, England : 1990)|September 27, 2022
Transplant-ineligible but chimeric antigen receptor T-cells eligible: a real and relevant populationSamuel Vic, Jean Lemoine, Philippe Armand, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2025
Longitudinal Patient-Reported Outcomes in Older Adults With Aggressive Lymphomas Receiving ChemoimmunotherapyP Connor Johnson, Jeremy S Abramson, Ann S LaCasce, et al.Blood Advances|March 4, 2020
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphomaReid W Merryman, Natasha Edwin, Robert Redd, et al.Leukemia & Lymphoma|August 8, 2022
Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantationEleanor Taranto, Robert Redd, Erin Jeter, et al.Hemasphere|January 17, 2020
Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?Annalisa Chiappella, Jennifer Crombie, Anna Guidetti, et al.Pageof 27